1. Yes. As described in the announcement no other adverse effects were observed.
2. The mice did not lose their fur. Having said this, this was not a model of alopecia.
3. It is progressing, but given the aim is to publish this work in one of the highest impact journals a great deal of work has to be done especially around the mechanism of action. While journal articles are nice to have, they are less important than progressing RC220.
- Forums
- ASX - By Stock
- Ann: Zantrene Protects Mouse Hearts from Chemotherapy Damage
1. Yes. As described in the announcement no other adverse...
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.82 |
Change
-0.015(0.82%) |
Mkt cap ! $316.9M |
Open | High | Low | Value | Volume |
$1.85 | $1.94 | $1.77 | $195.8K | 105.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9781 | $1.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.84 | 3842 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9781 | 1.810 |
1 | 1000 | 1.805 |
2 | 7373 | 1.800 |
2 | 1600 | 1.760 |
3 | 8043 | 1.750 |
Price($) | Vol. | No. |
---|---|---|
1.845 | 4464 | 3 |
1.850 | 1750 | 1 |
1.860 | 380 | 1 |
1.865 | 518 | 1 |
1.880 | 2351 | 1 |
Last trade - 15.26pm 25/09/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
BPH
BPH ENERGY LTD
David Breeze, Managing Director and Executive Chairman
David Breeze
Managing Director and Executive Chairman
SPONSORED BY The Market Online